Medications and teenagers: what's off the table

Why does diagnosis matter more for hair loss in teenagers?

Hair loss in a teenager is more likely than in an adult to have a cause other than pattern baldness, such as telogen effluvium, iron deficiency, thyroid disease, alopecia areata, traction, or trichotillomania. These have different treatments and some resolve on their own, so starting a pattern-loss drug without a diagnosis risks missing something treatable.

What hair-loss treatments are generally off the table for teenagers?

Finasteride and Dutasteride are generally avoided under 18, since safety and efficacy in this group are not established, and Dutasteride carries the same reasoning with a longer half-life. Surgery is also off the table, because the eventual pattern is unknown, and unregulated compounds bought online are a particular risk in this age group.

• Finasteride, not approved for under-18s and generally avoided; safety and efficacy in this group are not established
• Dutasteride, the same reasoning with a longer half-life
• Surgery, because the eventual pattern is unknown; the site's guideline is from around 25 once loss has stabilised
• Unregulated compounds bought online, which are a particular risk in this age group

What hair-loss treatment may be considered for teenagers?

Topical Minoxidil is sometimes used in adolescents under specialist supervision. The 2024 international consensus on low-dose oral Minoxidil described adolescent dosing of 0.625 mg/day for girls and 1.25 mg/day for boys aged 12 to 17, indicating specialists do prescribe it in this group, though only as a monitored, specialist decision.

Why do reputable clinics turn away young transplant applicants?

Reputable clinics turn away a meaningful share of very young applicants, which is good practice rather than lost business. Transplanting before the pattern is established risks a hairline that becomes isolated as loss continues behind it, spending donor supply that will be needed later in life.

Our guide on age and candidacy covers this.

Sources

1. Akiska YM, Mirmirani P, Roseborough I, Mathes E. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement. JAMA Dermatology, 2025;161(1):87-95. pubmed.ncbi.nlm.nih.gov/39565602
2. Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Finasteride for hair loss: a review. Journal of Dermatological Treatment, 2022;33(4):1938-1946. pubmed.ncbi.nlm.nih.gov/34291720

This article summarises published research. It is general educational information, not medical advice, and it is not a recommendation to start, stop or change any medication. Prescription drugs carry contraindications and interactions; discuss them with a doctor who knows your medical history.